$1.63
+0.18 (+12.41%)
Open$1.82
Previous Close$1.45
Day High$1.92
Day Low$1.53
52W High$4.93
52W Low$0.30
Volume—
Avg Volume4.33M
Market Cap7.65M
P/E Ratio—
EPS$-10.37
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.87M | 4.22M | 1.76M |
| Net Income | -117,938,070 | -91,891,838 | -56,960 |
| Profit Margin | -2,421.8% | -2,300.7% | -3.2% |
| EBITDA | -106,583,661 | -87,658,625 | -70,729 |
| Free Cash Flow | — | — | -37,098 |
| Rev Growth | +15.5% | +15.5% | +11.5% |
| Debt/Equity | 0.37 | 0.37 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.53 | -1.09% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $361.16 | +0.17% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.13 | -0.16% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $494.74 | -0.98% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $628.06 | -0.59% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $297.43 | +1.33% | 69.3 | 39.97B |